Evaluation of a Telemedicine System for Patient Inclusion in a Therapeutic Trial
Author Information
Author(s): Jean-François Lesesve, Richard Garand
Primary Institution: Centre Hospitalier Universitaire de Nancy et de Nantes
Hypothesis
Can telehaematology improve the inclusion of patients in chronic lymphocytic leukaemia trials?
Conclusion
Telehaematology can significantly speed up the second reading process for patient diagnosis in chronic lymphocytic leukaemia.
Supporting Evidence
- Telehaematology allows for faster validation of patient data compared to traditional methods.
- Overall agreement between experts was achieved in 72% of cases.
- Immunophenotypical diagnosis showed an 86% agreement among experts.
Takeaway
This study shows that using digital images to share patient data can help doctors make faster and better decisions about treatment.
Methodology
Patients' blood smears were digitized and sent to experts for analysis to assess the feasibility of telehaematology.
Potential Biases
Differences in expert interpretation could lead to variability in diagnosis.
Limitations
Some patient data were incomplete or lost, affecting the analysis.
Participant Demographics
Patients aged 18 to 60 with chronic lymphocytic leukaemia.
Statistical Information
Statistical Significance
p>0.2
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website